A 48-year-old woman from Odisha presents with multiple ill-defined erythematous plaques on her face, trunk, and limbs. On examination, she has 12 lesions with partial sensory loss. Slit-skin smear shows 4+ acid-fast bacilli. Lepromin test is weakly positive. She has no signs of neuritis. What is the most appropriate MDT regimen for this patient?

Explanation

## Classification and MDT Selection This patient has **borderline tuberculoid (BT) leprosy** transitioning toward **borderline lepromatous (BL)** disease, classified as **multibacillary (MB)** based on: - Multiple lesions (>5, here 12) - High bacterial load (4+ AFB on slit-skin smear) - Partial sensory loss (asymmetric but present) - Weakly positive lepromin test (indicates some cell-mediated immunity) - Ill-defined lesion borders ## WHO MDT Regimen for Multibacillary Leprosy **Key Point:** Multibacillary leprosy (BL, LL, BT with high bacillary load) requires **12-month MDT-MB** regimen. ### Standard MDT-MB Regimen | Drug | Dose | Frequency | Duration | |------|------|-----------|----------| | Rifampicin | 600 mg | Monthly supervised + daily unsupervised | 12 months | | Dapsone | 100 mg | Daily (unsupervised) | 12 months | | Clofazimine | 300 mg (monthly) + 50 mg (daily) | Mixed schedule | 12 months | **High-Yield:** MDT-MB = **RDC for 12 months** with 12 supervised doses of rifampicin and 12 supervised doses of clofazimine. ## Rationale for 12-Month Duration 1. **High bacillary load:** 4+ AFB requires prolonged therapy to sterilize lesions 2. **Relapse prevention:** 12 months reduces relapse rate to <1% in MB disease 3. **Bacterial clearance kinetics:** High-load disease needs extended rifampicin exposure 4. **WHO recommendation:** All MB forms (BL, LL, and BT with >5 lesions or >4+ AFB) receive 12-month MDT **Clinical Pearl:** The distinction between MB and PB is based on **bacillary load (slit-skin smear)** and **number of lesions**, NOT clinical classification alone. A BT patient with >5 lesions or high AFB count is treated as MB. ## Why Not 6 Months? **Warning:** 6-month MDT is insufficient for MB disease: - Relapse rate rises to 10–15% if only 6 months given - Bacterial sterilization is incomplete - Reserved only for paucibacillary forms (TT, BT with <5 lesions and low AFB) ## Why Not Ofloxacin-Based Regimen? Ofloxacin + minocycline + ofloxacin (12-month alternative) is used ONLY when: - Dapsone intolerance (hemolysis, PABA sensitivity) - Rifampicin resistance (rare) - HIV co-infection requiring drug interactions avoidance It is NOT first-line for standard MB leprosy.